XenoPort (XNPT) to Implement Workforce Reduction

Go back to XenoPort (XNPT) to Implement Workforce Reduction

XenoPort (XNPT) to Focus on HORIZANT, Names Vincent J. Angotti as CEO

October 1, 2015 4:07 PM EDT

XenoPort, Inc. (Nasdaq: XNPT) announced today a strategic shift to focus on and maximize the value of its commercial product, HORIZANT® (gabapentin enacarbil) Extended Release Tablets. As part of this shift, XenoPort will discontinue development of XP23829 on its own and seek to partner this and other high potential development stage... More